Treatment

Study Shows Children with Autism only 10 Percent More Likely to be Using Complementary and Alternative Medicine

Source: 
Journal of Developmental and Behavioral Pediatrics
Date Published: 
January 11, 2013
Abstract: 

A new study from the Journal of Developmental and Behavioral Pediatrics looked at nearly 600 children with ASD and with developmental delays. 40 percent of the children with autism in the study were using complementary and alternative medicine (CAM). While this may seem like a high percentage, it is only ten percent higher than the rate of nonautistic children in the study using CAM. The most common forms of complementary treatments reported were dietary supplements.

Long Neglected, Severe Cases of Autism Get Some Attention

Source: 
Simons Foundation Autism Research Institute
Abstract: 

Next February, researchers plan to begin work on a $1.2 million project that aims to link specialized psychiatric units across the U.S. to investigate the most severe and challenging autism cases. The study will include the six largest of the nine specialized psychiatric hospital programs for autism in the U.S. About 1,000 individuals with autism, aged 4 to 20, typically spend between 20 and 25 days at a time in these programs. “We think this is an area we can contribute [to],” says lead investigator Matthew Siegel, medical director of the developmental disorders program of Spring Harbor Hospital in Maine. “If not us, who? We have the expert clinicians and see hundreds of these kids.”

Oxytocin Improves Brain Function in Children with Autism

Source: 
Proceedings of the National Academy of Sciences
Date Published: 
December 2, 2013
Abstract: 

A new study conducted by the Yale Child Study Center shows promising results concerning the use of the hormone oxytocin. The study found that oxytocin, given as a nasal spray,enhanced brain activity while processing social information in children with autism spectrum disorders. This means brain centers associated with reward and emotion recognition responded more during social tasks when the children in the study received oxytocin.

Kids with Autism are Often on Many Medications at Once

Source: 
Pediatrics
Date Published: 
October 21, 2013
Abstract: 

According to a new study in the journal Pediatrics, kids with autism are often prescribed mood altering drugs, sometimes many at one time and for extended periods of time. These drugs include antipsychotics, antidepressants, and anti-anxiety medications. The study states that this practice occurs despite minimal evidence of the effectiveness or appropriateness of multidrug treatment of ASD.

Autism Drugs in Some Countries have Serious Side Effects

Source: 
Simons Foundation Autism Research Institute
Date Published: 
September 20, 2013
Abstract: 

The most popular drugs prescribed for autism in some countries often have serious side effects or have not been vetted in robust clinical trials, finds a survey published in the journal Psychopharmacology. Additionally, children with ASDs take more drugs than adults with ASDs. ADHD in children with autism may play a factor in this.

The Autism Science Foundation and the NIH Fund Study of Promising Treatment for Autism Subtypes

Source: 
Newswise
Date Published: 
August 26, 2013
Abstract: 

Scientists at the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai have received grants from the National Institutes of Health and the Autism Science Foundation to study Insulin-Like Growth Factor-1 (IGF-1), a promising treatment for subtypes of autism. Clinical Director at the Seaver Autism Center, Dr. Alex Kolevzon, says, "IGF-1 has the potential to be effective in treating Phelan-McDermid Syndrome and other types of autism spectrum disorder. We are very pleased that the NIH and the Autism Science Foundation have recognized this by providing us funding to continue our work in bringing this medication to our patients.”

Hear more from Dr. Alex Kolevzon on the ASF YouTube channel here.

FDA Warns Against Hyperbaric Oxygen Therapy for Autism

Source: 
U.S. Food and Drug Administration
Date Published: 
August 22, 2013
Abstract: 

The FDA has issued a warning against using Hyperbaric Oxygen Therapy (HBOT) in the treatment of autism. HBOT involves breathing oxygen in a pressurized chamber. This treatment has not been cleared by the FDA for the treatment of autism, though there are some places on the internet that falsely claim it has. The FDA urges people to work with their health care professional to determine their best choice for treatment.

A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism.

Source: 
Biol Psychiatry
Date Published: 
June 1, 2012
Year Published: 
2012
Abstract: 

The goal of this pilot study was to assess the feasibility of using oral N-acetylcysteine (NAC), a glutamatergic modulator and an antioxidant, in the treatment of behavioral disturbance in children with autism.

Seaside Therapeutics Discontinues Arbaclofen (STX209) Extension Study

Source: 
The Boston Globe
Date Published: 
May 31, 2013
Abstract: 

Seaside Therapeutics has discontinued their extension study of Arbaclofen (STX209), a drug that showed promise in treating social impairment related to Fragile X syndrome.

How Can Immigrant Families Get Help For Their Autistic Child

Source: 
ASF Blog
Date Published: 
May 24, 2013
Abstract: 

Guest blogger Marcela De Vivo shares insight on some of the difficulties immigrant families face when getting help for their child with autism in this week's ASF blog post.